Multiple Sclerosis International Federation

 
 
News
Donate advanced search
print version print this page
 

inside
News:

 

  New findings on Copaxone
Researchers have found a new explanation for the effects of Copaxone® (glatiramer acetate, Teva Pharmaceuticals), a treatment approved for relapsing-remitting multiple sclerosis.

Nitin J. Karandikar, MD, PhD (University of Texas Southwestern Medical Center, Dallas), a Harry Weaver Neuroscience Scholar of the National MS Society, and colleagues report their findings in the Journal of Immunology (2006 Jun 1;176(11):7119-29).

Copaxone is a synthetic compound made up of four amino acids (the building blocks of proteins) that are found in myelin. This drug is thought to stimulate one type of T cell (called a CD4+ T cell) in the body’s immune system to change from pro-inflammatory agents that attack the brain and spinal cord in MS, to beneficial agents that work to reduce inflammation at sites of damage in the nervous system.

To read more, please click on the link below.


Source: US National MS Society
Weblink: click here

Copyright &<br>Link Policy Copyright &
Link Policy
Privacy Policy Privacy Policy back to top
Disclaimer Disclaimer Acknowledgements Acknowledgements
back to top  back to top  
Email Update Email Update Edit User Details Edit User Details Feedback Feedback Glossary Glossary Site Map Site Map
Back to top Back to top